Partners from the Medical Technology industry can propose, shape and participate in nationally and internationally funded research projects through various Swiss national funding programmes. To develop new products or services for the benefit of patients and medical personnel, CAIM offers pre-agreed access terms for newly developed IP so that researchers maintain their independance and industry can simultanously gain early access to cutting-edge technological innovation.
